Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport(®)) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction—Case Studies

Erectile dysfunction (ED) is a highly prevalent condition with a variety of possible risk factors and/or etiologies. Despite significant advances regarding ED pharmacological management, there are still insufficient responders to existing pharmacological treatments e.g., approximately 30% of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Francois, Joussain, Charles, Denys, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563248/
https://www.ncbi.nlm.nih.gov/pubmed/31117236
http://dx.doi.org/10.3390/toxins11050283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563248/
https://www.ncbi.nlm.nih.gov/pubmed/31117236
http://dx.doi.org/10.3390/toxins11050283

Ejemplares similares